New Promising Treatments for Advanced Prostate Cancer2020;382:2187-2196). The primary endpoint was sustained testosterone suppression to castrate levels (< 50 ng/dL) through 48 weeks in the treated population.doi:10.1097/01.COT.0000695672.84740.75Kumar Das, Dibash...
New treatments for localized tumours—what matters first?doi:10.1038/nrurol.2012.133B. GuillonneauNature Reviews Urology
S241 NEW TREATMENTS FOR PATIENTS WITH LOW RISK LOCALIZED PROSTATE CANCER - ACTIVE SURVEILLANCE, FOCAL THERAPY - IS DECISION FOR DEPENDENT JUST ON UROLOGIST? O. Durutovic, M. Acimovic, N. Bojanic, P. Nikic, N. Ladjevic, A. Mimic, B. Cegar, B. Milojevic, V. Andrejevic, ...
New treatments based on gene therapy approaches to increase radiosensitisation in prostate cancerMicrograntsCase studyAdolescentPhysical activitySportQualitativeProstate Cancer and Prostatic Diseases, covering all aspects of prostatic diseases, in particular prostate cancer. The journal is of interest to ...
According to Kumar, because of the high need for newer therapies future considerations for multiple myeloma treatment are currently in development and are showing promise in clinical trials. One of these potential treatments is iberdomide (CC-220; Bristol Myers Squibb), and like lenalidomide (Revlim...
Prostate cancer affects one in every eight men during their lifetime, making it the most prevalent form of cancer for males. For many, the standard of care means facing aggressive treatments that include radiation and the freezing or removal of the entire prostate, which often result in incontin...
Normal cell growth is controlled by stringent regulatory mechanisms; however, alterations in specific cell components can lead to dysfunction in these mechanisms, resulting in cancer [3]. Cancer treatments are tailored based on the type and stage of cancer, as well as the patient's overall health...
Despite significant advancements in treatment, includ- ing the development of tailored therapies for various subtypes such as luminal A, luminal B, HER-2 overex- pression, and triple-negative breast cancer (TNBC) [1], conventional treatments like radiation and chemotherapy often damage healthy cells...
They also protected the cancer cells against oxidative stress and ROS induced cytotoxicity imposed by 5-FU exposure [59]. Interaction between myeloid-derived suppressor cells (MDSCs) and IL-6 can drive the chemoresistant phenotype of HCC, suggesting that treatments targeting MDSCs may prove to be...
This enables CAR-T cells to effectively target and eliminate the cancer cells. To overcome these challenges, future treatment approaches for tumors will likely involve combining immunotherapy-based treatments, such as CAR-T cell therapy, with other treatment modalities [51]. NHL The recent approval ...